Hyundai Bio Secures Mass Production System for Oral COVID-19 Treatment
[Asia Economy Reporter Hyunseok Yoo] Hyundai Bio announced on the 16th that it has signed a formulation development contract for the contract manufacturing and production of the oral COVID-19 treatment CP-COV03 with Yooyoung Pharmaceutical, jointly with its major shareholder CNPharm.
Founded in 1981, Yooyoung Pharmaceutical is a mid-sized pharmaceutical company that recorded sales of 111.2 billion KRW last year. With an annual oral drug production capacity of 800 million tablets, Hyundai Bio will establish a mass production system for CP-COV03 through this contract.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- JD Vance: "Iran Must Agree to Abandon Nuclear Weapons... Military Action Remains an Option"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
According to the contract, Yooyoung Pharmaceutical will produce CP-COV03, developed as an oral drug by CNPharm, into formulations such as tablets or capsules suitable for human consumption and supply them primarily for clinical trials. It also holds the top priority manufacturing negotiation rights for commercial products. Hyundai Bio and CNPharm plan to conduct clinical trials of CP-COV03 using Yooyoung Pharmaceutical’s commercial formulations.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
